Join to view full profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-606-1000
Fax+1 206-606-1025
Dr. Shadman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2011 - 2014
Cleveland Clinic FoundationResidency, Internal Medicine, 2008 - 2011
University of WashingtonMPH, Cancer Epidemiology , 2006 - 2008
Tehran University of Medical Sciences School of MedicineClass of 2004
Certifications & Licensure
WA State Medical License 2011 - 2027
OH State Medical License 2008 - 2011
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Trainee Research Award American Society of Hematology (ASH)
Clinical Trials
- Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Publications & Presentations
PubMed
- Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network...Mazyar Shadman, Walter Bouwmeester, Leyla Mohseninejad, Sheng Xu, Milica Jevdjevic
Journal of Medical Economics. 2026-12-01 - Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia.Isabelle Fleury, Brian T Hill, Toby A Eyre, Chaitra Ujjani, Beenish S Manzoor
Blood Neoplasia. 2026-11-01 - Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.Taha Al-Juhaishi, Kwang Woo Ahn, Tiening Chen, Krina K Patel, Jinalben Patel
Transplantation and Cellular Therapy. 2026-10-01
Journal Articles
- Translating Anti-CD19 CAR T-cell Therapy into Clinical Practice for relapsed/refractory Diffuse Large B-cell LymphomaMazyar Shadman, Ajay K Gopal, Victor A Chow, Blood
Abstracts/Posters
- Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell TherapyMazyar Shadman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic TrialsMazyar Shadman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy and Safety of Zanubrutinib in Patients with Treatment-Naive Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with Del(17p): Initial Resu...Mazyar Shadman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Fred Hutch Appoints Chief Medical OfficersMarch 11th, 2026- For Many Blood Cancer Patients, CAR T-cell Therapy Is Game-ChangingDecember 5th, 2025
- Fred Hutch at ASH: Expanding CAR-T Access, AML Treatment Strategies, Climate and Cancer — and ASH Lifetime Achievement AwardDecember 3rd, 2025
Professional Memberships
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: